Peer-reviewed veterinary case report
Accuracy of three dog antibody tests for core vaccines compared
By Lena Janowitz et al.·Published in Veterinary Sciences·2025·Clinical Laboratory, Department of Clinical Diagnostics and Services, and Centre for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland, CH·View original on DOAJ →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Antibody Titer Testing in Dogs: Evaluation of Three Point-of-Care Tests for Canine Core Vaccine Antigens Compared to Virus Neutralization
- Species:
- dog
Plain-English summary
A group of dogs was tested for their immunity to common viruses after vaccination, specifically looking at canine parvovirus, canine distemper virus, and canine adenovirus. Three different point-of-care tests were evaluated to see how well they detected antibodies compared to a standard lab test. The tests were generally good at identifying immunity to parvovirus, but some had issues with the other viruses, which could lead to misdiagnosing unprotected dogs as immune. The best test for parvovirus also worked well for puppies with maternal antibodies. Overall, these tests can help reduce unnecessary vaccinations in adult dogs, but improvements are needed for the other viruses.
People also search for: dog vaccine titer test · canine parvovirus immunity test · puppy vaccination antibody test
Abstract
Antibody titer testing can be useful in controlling successful puppy immunization and can reduce unnecessary vaccinations in adult dogs. We evaluated three commercially available point-of-care tests (POCTs) for detecting antibodies against canine parvovirus (CPV-2), canine distemper virus (CDV) and canine adenovirus (CAV-1 and/or -2), comparing them to the reference virus neutralization (VN) assay. Sera from 200 client-owned dogs (13 healthy, 63 chronically diseased, 124 acute) and 60 specific pathogen-free (SPF) dogs, including 20 sera with maternally derived antibodies (MDA), were tested. All three POCTs demonstrated high sensitivity (79.0–100%) and specificity (97.8–100%) for CPV-2. In contrast, specificity for CDV and CAV was lower with POCT-1 (43.5% and 55.3%) and POCT-2 (42.4% and 79.2%), despite high sensitivity (CDV in both POCTs 98.7%; CAV POCT-1: 99.4%, POCT-2: 90.8%). POCT-3, by comparison, showed high specificity (CDV: 94.1%; CAV: 84.4%) but very low sensitivity (CDV: 17.4%; CAV: 33.1%). Only POCT-1 for CPV-2 detected MDA reliably, whereas the other two POCTs, and POCT-1 for CDV and CAV, did not. When compared to VN, the agreement in vaccination recommendations was 82% for POCT-1 and POCT-2, and 62% for POCT-3. In conclusion, all three POCTs reliably detected antibodies against CPV-2, including MDA with POCT-1. However, the lower specificity for CDV and CAV antibody detection in POCT-1 and POCT-2 raises concerns about misclassifying unprotected dogs as immune, while false-negatives with POCT-3 could lead to unnecessary vaccinations. Further optimization of all three POCTs for CDV and CAV is recommended.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on DOAJ: https://doi.org/10.3390/vetsci12080737